FY 2021 Appropriations Provides FDA Healthy Boost – Plus More COVID-19 Funds
Executive Summary
Budget authority increase for medical product safety is coupled with additional funds for coronavirus countermeasure development and advanced manufacturing.
You may also be interested in...
Congress Gives US FDA Austere Budget But Seeks Boosts On Inspections, IT, And ALS Activities
The minor cut would be masked by user fee revenue increases, but still would be the first time in at least a decade that agency's budget authority has dropped.
Surprise US FDA Facility Inspections Resume In India
Unannounced facility visits also were to start again in China, but FDA Commissioner Robert Califf said they have been delayed by the COVID-19 outbreak in the country.
US FDA’s In-Person Foreign Inspections Remain On House Appropriators’ Minds
The House Appropriations Committee also does not want the agency to become too dependent on alternative inspection tools.